Antigliadin Antibodies Associated with Chronic Mucocutaneous Candidiasis
Autor: | Santiago Gómez Díez, Narciso Perez Oliva, Yolanda Hidalgo Garcia, Lourdes Tricas Aizpún |
---|---|
Rok vydání: | 2002 |
Předmět: |
Male
medicine.medical_specialty Antifungal Agents Adolescent Mucocutaneous zone Dermatology Antibodies Gliadin Recurrence medicine Humans Chronic mucocutaneous candidiasis Candida albicans Fluconazole Recurrent upper respiratory tract infections Mycosis biology business.industry Candidiasis Chronic Mucocutaneous medicine.disease biology.organism_classification Treatment Outcome Otitis Pediatrics Perinatology and Child Health Immunology Primary immunodeficiency Oral thrush Itraconazole medicine.symptom business |
Zdroj: | Pediatric Dermatology. 19:415-418 |
ISSN: | 1525-1470 0736-8046 |
DOI: | 10.1046/j.1525-1470.2002.00117.x |
Popis: | Chronic mucocutaneous candidiasis (CMC) is a primary immunodeficiency disease clinically characterized by Candida infection of the skin, mucous membranes, or nails that is refractory to traditional treatment. We present a typical case of a 13-year-old boy with an onset of illness at 1 month of age in the form of oral thrush. At age 2-3 years the patient began to have external otitis caused by Candida albicans and recurrent upper respiratory tract infections. Analytical studies detected iron deficiency and circulating antigliadin antibodies. Immunologic findings excluded other possible immunodeficiencies. Significant clinical improvement was produced by therapy with orally administered fluconazole. The significance of antigliadin antibodies is discussed. |
Databáze: | OpenAIRE |
Externí odkaz: |